Skip to Content

93 294 (Carbidopa and Levodopa 25 mg / 250 mg)

Pill with imprint 93 294 is Blue, Round and has been identified as Carbidopa and Levodopa 25 mg / 250 mg. It is supplied by Teva Pharmaceuticals USA.

Carbidopa/levodopa is used in the treatment of parkinson's disease; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 25 mg / 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 93 294

Carbidopa and levodopa 25 mg / 250 mg 93 294 Front
Carbidopa and levodopa 25 mg / 250 mg 93 294 Back
Carbidopa and levodopa 25 mg / 250 mg 93 294
Carbidopa and levodopa 25 mg / 250 mg 93 294
Carbidopa and levodopa 25 mg / 250 mg 93 294

Carbidopa and Levodopa

Imprint
93 294
Strength
25 mg / 250 mg
Color
Blue
Size
10.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Dopaminergic antiparkinsonism agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
Inactive Ingredients
magnesium stearate, microcrystalline cellulose, corn starch, FD&C Blue No. 2

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00093-0294 Teva Pharmaceuticals USA, Inc.
63739-0048 McKesson Packaging Services

Get help with Imprint Code FAQs.

Related Images for "93 294"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.